NKTX
NKTX
NASDAQ · Biotechnology

Nkarta Inc

$2.11
+0.11 (+5.50%)
As of Mar 31, 10:10 PM ET ·
Financial Highlights (FY 2025)
Revenue
19.33M
Net Income
-947,103
Gross Margin
48.5%
Profit Margin
-4.9%
Rev Growth
+21.0%
D/E Ratio
0.36
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 48.5% 48.5% 48.5%
Operating Margin -4.0% -4.1% -4.5%
Profit Margin -4.9% -4.4% -5.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.33M 18.18M 17.68M
Gross Profit 9.38M 8.82M 8.57M
Operating Income -777,479 -748,002 -791,319
Net Income -947,103 -802,247 -886,084
Gross Margin 48.5% 48.5% 48.5%
Operating Margin -4.0% -4.1% -4.5%
Profit Margin -4.9% -4.4% -5.0%
Rev Growth +21.0% +13.7% -3.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.23M 29.20M 25.01M
Total Equity 79.20M 66.12M 75.56M
D/E Ratio 0.36 0.44 0.33
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,287,077 -1,124,832 -1,061,399
Free Cash Flow -739,760 -479,993 -441,081